title: Medications to Assist in Tobacco Cessation for Dental Patients.
abstract: Smoking is the leading cause of preventable illness in the United States. Without assistance, only 3% to 6% of smokers successfully quit after 1 year. Nicotine replacement therapy (NRT), buproprion, and varenicline are first-line pharmacologic therapies. These medications function by reducing nicotine withdrawal symptoms and the desire to smoke. When first-line therapy does not lead to successful smoking cessation, combinations of varenicline with NRT, buproprion with NRT, and varenicline with buproprion may be efficacious. Behavioral therapy also plays a role in smoking cessation and the combination of pharmacologic therapy with behavioral therapy is more effective than either therapy alone.
authors.affiliation: Division of Oral and Maxillofacial Surgery, Department of Surgery, Emory University School of Medicine, 1365 Clifton Road, Suite 2300, Building B, Atlanta, GA 30322, USA.
authors.forename: Joshua M
authors.initials: JM
authors.lastname: Levy
authors.affiliation: Division of Oral and Maxillofacial Surgery, Department of Surgery, Children's Healthcare of Atlanta, Emory University School of Medicine, 1365 Clifton Road, Northeast, Suite 2300 Building B, Atlanta, GA 30322, USA. Electronic address: sabram5@emory.edu.
authors.forename: Shelly
authors.initials: S
authors.lastname: Abramowicz
mesh_terms: D000279:Administration, Cutaneous; D006801:Humans; D009538:Nicotine / Q000627:therapeutic use; D018722:Nicotinic Agonists / Q000627:therapeutic use*; D012907:Smoking / Q000188:drug therapy; D016540:Smoking Cessation
chemical_list: D018722:Nicotinic Agonists; D009538:Nicotine
keywords: Nicotine gum; Nicotine patch; Nicotine replacement therapy; Smoking cessation